نتایج جستجو برای: Pheochromocytomas (PCCs)

تعداد نتایج: 1151  

Pheochromocytomas (PCCs) are rare neuroendocrine tumors. The current diagnostic tools are based on biochemistry and histopathology results, but heterogeneity of diagnostic markers, signs and symptoms of PCCs bring a lot of difficulties for these two current methods. Unfortunately microscopic understanding of PCCs is not adequate for its confident prognosis and management. There are data linking...

2014
Amrallah A. Mohammed Ayman M. El-Shentenawy Mohamed A. Sherisher Hani M. El-Khatib

Most of the pheochromocytomas (PCCs) are benign neoplasms, but when they are malignant, they can be difficult to treat. Despite advances in diagnosis and imaging, it remains an untreatable tumor, when metastases develop. A deeper understanding of the alteration of the specific molecular pathways causing malignant PCCs might hopefully lead in the future to the development of multiple molecular-t...

2017
Fatemeh Khatami Seyed Mohammad Tavangar

Pheochromocytomas (PCCs) are rare neuroendocrine tumors. The current diagnostic tools are based on biochemistry and histopathology results, but heterogeneity of diagnostic markers, signs and symptoms of PCCs bring a lot of difficulties for these two current methods. Unfortunately, microscopic understanding of PCCs is not adequate for its confident prognosis and management. There are data linkin...

2015
C. Christofer Juhlin Adam Stenman Felix Haglund Victoria E. Clark Taylor C. Brown Jacob Baranoski Kaya Bilguvar Gerald Goh Jenny Welander Fredrika Svahn Jill C. Rubinstein Stefano Caramuta Katsuhito Yasuno Murat Günel Martin Bäckdahl Oliver Gimm Peter Söderkvist Manju L. Prasad Reju Korah Richard P. Lifton Tobias Carling

As subsets of pheochromocytomas (PCCs) lack a defined molecular etiology, we sought to characterize the mutational landscape of PCCs to identify novel gene candidates involved in disease development. A discovery cohort of 15 PCCs wild type for mutations in PCC susceptibility genes underwent whole-exome sequencing, and an additional 83 PCCs served as a verification cohort for targeted sequencing...

2015
Helene Myrtue Nielsen Alexandre How-Kit Carole Guerin Frederic Castinetti Hans Kristian Moen Vollan Catherine De Micco Antoine Daunay David Taieb Peter Van Loo Celine Besse Vessela N Kristensen Lise Lotte Hansen Anne Barlier Frederic Sebag Jörg Tost

Overexpression of insulin growth factor 2 (IGF2) is a hallmark of adrenocortical carcinomas and pheochromocytomas. Previous studies investigating the IGF2/H19 locus have mainly focused on a single molecular level such as genomic alterations or altered DNA methylation levels and the causal changes underlying IGF2 overexpression are still not fully established. In the current study, we analyzed 6...

Journal: :Disease and diagnosis 2023

Background: Pheochromocytomas (PCCs) are catecholamine-producing neuroendocrine tumors that originate from the adrenal medulla. Their clinical presentations most commonly include hypertension, headache, palpitations, and sweating; however, PCCs sometimes normotensive clinically silent. Case Presentation: A female patient with abdominal pain as well persistent crushing left flank for past six mo...

2015
Antje M. Richter Tobias Zimmermann Tanja Haag Sara K. Walesch Reinhard H. Dammann

Pheochromocytomas (PCCs) are rare neuroendocrine tumors that arise from the medulla of the adrenal gland or the sympathetic ganglia and are characterized by the secretion of catecholamines. In 30-40% of patients, PCCs are genetically determined by susceptibility genes as various as RET, VHL, and NF1. We have analyzed the Ras-association domain family members (RASSFs) in PCCs regarding their ina...

2015
Marcia Helena Soares Costa Tania M. Ortiga-Carvalho Alice Dutra Violante Mario Vaisman

Pheochromocytomas (PCCs) and paragangliomas (PGLs) are neuroendocrine tumors derived from the chromaffin tissue. Diagnosis of these tumors is extremely important as they are linked to the hypertension syndrome with great cardiovascular morbidity and mortality. A great majority of PCCs and PGLs are sporadic and benign tumors; however, the classic idea of 10% exception of these features is changi...

2001
STEVEN W. J. LAMBERTS FRANS BOOMSMA THEO STIJNEN ERIC P. KRENNING FRED T. BOSMAN DIK J. KWEKKEBOOM

Selecting the appropriate approach for resection and follow-up of pheochromocytomas (PCCs) is highly dependent upon reliable localization and exclusion of multifocal, bilateral, or metastatic disease. Metaiodobenzylguanidine (MIBG) scintigraphy was developed for functional localization of catecholamine-secreting tissues. Somatostatin receptor imaging (SRI) has a high sensitivity for localizing ...

2012
Esther Korpershoek Karel Pacak Lucia Martiniova

Pheochromocytomas (PCCs) are slow-growing neuroendocrine tumors arising from adrenal chromaffin cells. Tumors arising from extra-adrenal chromaffin cells are called paragangliomas. Metastases can occur up to approximately 60% or even more in specific subgroups of patients. There are still no well-established and clinically accepted "metastatic" markers available to determine whether a primary t...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید